Literature DB >> 13803289

The selective accumulation of bretylium in sympathetic ganglia and their postganglionic nerves.

A L BOURA, F C COPP, W G DUNCOMBE, A F GREEN, A McCOUBREY.   

Abstract

A study of the distribution of [(14)C]-labelled bretylium (N-o-bromobenzyl-N-ethyl-N,N-dimethylammonium) in cat tissues at various times after subcutaneous injection suggests that the specificity of its blocking action on adrenergic neurones may be related to its selective accumulation in these neurones. The rate of rise and fall of concentration in sympathetic ganglia and postganglionic sympathetic nerves showed a close similarity to the time course of the blocking adrenergic neurones as manifested by relaxation of the nictitating membranes. Concentrations found were similar to those in adrenergic nerve trunks when topical application of the drug had caused a local block of conduction. Conduction in other types of nerve could be blocked by topical application, but in general they were less sensitive, heavily myelinated nerves being the most resistant.

Entities:  

Keywords:  SYMPATHOLYTICS/metabolism

Mesh:

Substances:

Year:  1960        PMID: 13803289      PMCID: PMC1481934          DOI: 10.1111/j.1476-5381.1960.tb01242.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  4 in total

1.  Bretylium tosylate in the treatment of hypertension.

Authors:  C T DOLLERY; D EMSLIE-SMITH; J McMICHAEL
Journal:  Lancet       Date:  1960-02-06       Impact factor: 79.321

2.  Choline 2 : 6-xylyl ether bromide; an active quaternary local anaesthetic.

Authors:  P HEY; G L WILLEY
Journal:  Br J Pharmacol Chemother       Date:  1954-12

3.  The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs.

Authors:  M VOGT
Journal:  J Physiol       Date:  1954-03-29       Impact factor: 5.182

4.  The excretion and stability to metabolism of bretylium.

Authors:  W G DUNCOMBE; A McCOUBREY
Journal:  Br J Pharmacol Chemother       Date:  1960-06
  4 in total
  26 in total

1.  On the mechanism of the accumulation of 3H-bretylium in peripheral sympathetic nerves.

Authors:  S B Ross; T Gosztonyi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Adrenergic neurone blockade and other acute effects caused by N-benzyl-N'N"-dimethylguanidine and its ortho-chloro derivative.

Authors:  A L BOURA; A F GREEN
Journal:  Br J Pharmacol Chemother       Date:  1963-02

3.  A new view of adrenergic nerve fibres, explaining the action of reserpine, bretylium, and guanethidine.

Authors:  J H BURN
Journal:  Br Med J       Date:  1961-06-10

4.  ANTAGONISM OF THE BLOCKING ACTION OF BRETYLIUM AND GUANETHIDINE ON THE PRESSOR EFFECT OF PHYSOSTIGMINE IN THE RAT.

Authors:  S D GOKHALE; O D GULATI; N Y JOSHI
Journal:  Br J Pharmacol Chemother       Date:  1965-06

5.  Analysis of he responses of the isolated stomach to electrical stimulation and to drugs.

Authors:  W D PATON; J R VANE
Journal:  J Physiol       Date:  1963-01       Impact factor: 5.182

6.  Studies on sympathetic mechanisms in isolated intestinal and vas deferens preparations.

Authors:  G A BENTLEY
Journal:  Br J Pharmacol Chemother       Date:  1962-08

7.  Supersensitivity of salivary glands following treatment with bretylium or guanethidine.

Authors:  N EMMELIN; J ENGSTROM
Journal:  Br J Pharmacol Chemother       Date:  1961-06

8.  Influence of cocaine and sodium on bretylium uptake by reserpine-treated guinea-pig left atrium.

Authors:  A G García; P Sánchez-García
Journal:  Br J Pharmacol       Date:  1975-02       Impact factor: 8.739

9.  The relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives.

Authors:  E T Abbs; M G Dodd
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

10.  Studies on the mode of action of bretylium and guanethidine in post-ganglionic sympathetic nerve fibres.

Authors:  J A Brock; T C Cunnane
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.